Rangeley Capital Podcast
June 2019: Will T-Mobile's Sprint call connect? Plus how Abbvie's Allergan deal is giving shareholders wrinkles
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:22:22
- Mas informaciones
Informações:
Sinopsis
Following a month of blockbuster M&A, the Rangeley team discusses how Abbvie's deal is giving their shareholders stress wrinkles. Then, they talk about the Sprint / T-Mobile deal as it (apparently) nears DOJ approval.